Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil Larissa Hilario Dulley; Arthur Gomes Oliveira Braga; Guilherme Garcia Rodrigues; Sergio Costa Fortier; Carlos Sérgio Chiattone; Talita Maira Bueno da Silveira;

Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method Astrid Pavlovsky; Juan Ignacio Garcia Altuve; Amalia Cerutti; Lorena Fiad; Nicolás Kurgansky; Fernando Warley; Florencia Negri Aranguren;

Hematologic malignancies of primary bone marrow involvement: a decade's experience in Bahrain Amina Ismaeel; Eman Farid; Kameela S. Majed; Eman Jasim Mansoor; Jalal Toorani; Faisal Tufail; Romysaa Abdulla Aldanasoury; Sara Ali Alsuwaidi; Durjoy Kumar Shome;